The board of directors of Macro Group Pharmaceutical (Macro Capital) (MCRO) has proposed the distribution of EGP 40 million in cash dividends for the full year ended December 31st 2021, according to a filing to the Egyptian Exchange (EGX) on Tuesday.
The dividends amount is equivalent to EGP 0.0692 per share.
Macro Group’s net profit after tax grew to EGP 147.967 million in 2021, from EGP 135.129 million in 2020.
Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.
